Sellbyville, DE -- (SBWIRE) -- 11/14/2018 -- Global Esoteric Testing Market was valued over USD 19 billion in 2017 and is expected to witness around 9.4% CAGR growth from 2018 to 2024.

Increasing incidences of rare and complex diseases coupled with growing awareness about early disease diagnosis and treatment will drive esoteric testing market over the forecast period. According to European Commission, nearly 27 to 36 million people suffer from rare disease in European region.
Rapidly improving healthcare sector in developing countries along with rising number of sophisticated laboratories offering advanced services will favour industry growth. Growing number of baby boomers prone to suffer from several chronic conditions will act as high impacting factor for industry growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1922

ELISA business segment held over 20% of business share in 2017 and will witness more than 9.5% growth from 2018 to 2024. Moreover, ELISA is common technique for basic research, high throughput screening performed in laboratories, and drug discovery program. New developments in biomarker field leading to availability of new targets will generate revenue growth for the segment.

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
1. Genomic Health
2. ARUP Laboratories
3. ACM Global Laboratories
4. American Esoteric Laboratories
5. Fulgent Genetics
6. OPKO Health, Inc.
7. Myriad Genetics
8. Litholink / Laboratory Corporation of America
9. Mayo Medical Laboratories
10. Miraca Holdings Inc.
11. Nordic Immunological laboratories BV
12. Quest Diagnostics

Chemiluminescence business segment dominated esoteric testing industry in 2017 and is anticipated to witness over 10% CAGR growth owing to high adoption of chemiluminescence in esoteric testing due to its high efficiency along with necessity of small sample. Superior sensitivity and accuracy delivered by this technology using low analyte concentration will further stimulate business growth.

U.S. esoteric testing market accounted for around 35% of the global industry share in 2017. Increasing prevalence of rare and complex diseases along with advancements in medical research will drive U.S. esoteric testing market over the coming years. Government initiated programs such as Obama Precision Medicine Initiative should positively impact industry growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1922

Esoteric Testing Market by Test-type
o Endocrinology
o Infectious disease & immunology
o Oncology
o Toxicology
o Neurology
o Genomics

Esoteric Testing Market by Technology
o Mass spectrometry
o Flow cytometry
o ELISA
o Radioimmunoassay
o Chemiluminescence
o RT-PCR